|
|
Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Betaxolol#Adverse Reactions]] |
| {{Betaxolol}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Adverse Reactions==
| |
| The following adverse reactions have been reported in clinical trials with BETOPTIC Ophthalmic Solution.
| |
| | |
| ===Ocular===
| |
| | |
| Discomfort of short duration was experienced by one in four patients, but none discontinued therapy; occasional tearing has been reported. Rare instances of decreased corneal sensitivity, [[erythema]], itching sensation, corneal punctate staining, [[keratitis]], [[anisocoria]], [[edema]], and [[photophobia]] have been reported.
| |
| | |
| Additional medical events reported with other formulations of betaxolol include blurred vision, foreign body sensation, dryness of the eyes, inflammation, discharge, ocular pain, decreased visual acuity, and crusty lashes.
| |
| | |
| ===Systemic===
| |
| | |
| Systemic reactions following administration of BETOPTIC Ophthalmic Solution 0.5% or BETOPTIC S Ophthalmic Suspension 0.25% have been rarely reported. These include:
| |
| | |
| ===Cardiovascular===
| |
| | |
| [[Bradycardia]], heart block and congestive failure.
| |
| | |
| ===Pulmonary===
| |
| | |
| Pulmonary distress characterized by [[dyspnea]], [[bronchospasm]], thickened bronchial secretions, [[asthma]] and [[respiratory failure]].
| |
| | |
| ===Central Nervous System===
| |
| | |
| [[Insomnia]], [[dizziness]], [[vertigo]], [[headache]]s, [[depression]], [[lethargy]], and increase in signs and symptoms of [[myasthenia gravis]].
| |
| | |
| ===Other===
| |
| | |
| [[Hives]], [[toxic epidermal necrolysis]], hair loss and [[glossitis]].
| |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BETOPTIC (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [ALCON] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31b9b263-11fd-4495-83dd-ababf0d70e9e | publisher = | date = | accessdate = 3 February 2014 }}</ref>
| |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
|
| |
|
| [[Category:Beta blockers]] | | [[Category:Beta blockers]] |
| [[Category:Cardiovascular Drugs]] | | [[Category:Cardiovascular Drugs]] |
| [[Category:Drugs]] | | [[Category:Drugs]] |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |